Health & Safety Guidelines
Effective: December 20, 2021 – Subject to Change
To ensure the safety of our attendees, speakers, exhibitors, and staff, the ACS Division of Fluorine Chemistry has incorporated the following health and safety protocols. Informed by the guidance and requirements of the U.S. Center for Disease Control (CDC), and other local regulations regarding COVID safety practices, this Attendee Safety Plan is subject to change as needed.
IMPORTANT: In light of events surrounding COVID-19, this is an appropriate time to remind ourselves of the risks incident to participating in the 26th Winter Fluorine Conference. Even with every reasonable precaution to keep you safe as outlined for you by the CDC, ACS Division of Fluorine Chemistry cannot fully eliminate all risks of harm to attendees or guarantee their safety, especially from risks posed by COVID-19 or its variant strains. Ultimately you are responsible for your own safety.
Failure to adhere to the following requirements could lead to removal from the venue or other disciplinary action.
- All attendees, speakers, exhibitors, guests, vendors, and ACS staff who attend the in-person meeting in Clearwater, FL are required to be fully vaccinated against COVID-19 at the time of the event or provide proof of a negative COVID-19 PCR test that has been taken within 48 hours of arriving at the conference.
- All attendees must be fully vaccinated against COVID-19 by December 25, 2022, 14 days from the start of the meeting, or provide proof of a negative COVID-19 PCR test that has been taken within 48 hours of arriving at the conference.
- According to the Centers for Disease Control (CDC), individuals are considered fully vaccinated for COVID-19 two weeks after they have received the second dose in a two-dose series (Pfizer/BioNTech or Moderna), or two weeks after they have received a single-dose vaccine (Johnson & Johnson's/Janssen).
- All attendees are required to upload proof of vaccination before attending this meeting. ACS Division of Fluorine Chemistry has partnered with Clear to administer the collection of vaccine documentation. Once registered attendees will be notified via text with instructions on how to upload their vaccination cards for validation. Once the card is uploaded, reviewed, and validated, Clear will send a text message back (email for international) indicating if the card has been validated and/or an explanation as to why the card has not been validated and/or requires additional action.
- This guidance applies to COVID-19 vaccines authorized for use and for emergency use by the U.S. Food and Drug Administration (i.e., Pfizer-BioNTech, Moderna, and Johnson and Johnson (J&J)/Janssen, Oxford/AstraZeneca, Covishield, Covaxin, Sinopharm/BBIBP-CorV, and Sinovac/CoronaVac). The full list of vaccines with final WHO evaluation status is available at the World Health Organization. ACS Division of Fluorine Chemistry may expand the list of vaccines, provide more specific guidance regarding mixed vaccination dosing, and/or provide additional guidance regarding boosters as prevailing public health guidance evolves. Watch this space for additional details as we get closer to 26th Winter Fluorine.
Additional restrictions on participants may come in accordance with the Center of Disease Control and Prevention (CDC) guidelines and applicable federal, state, or local governmental orders, regulations, and/or guidelines intended to reduce the spread and risks of exposure to COVID-19.
- ACS is recommending that all attendees, speakers, exhibitors, guests, vendors, and ACS staff wear a face mask (except when actively eating or drinking) while in the meeting venue, or attending any facility hosting an ACS-sponsored event or meeting. Masks will be available on-site.
- A recommended mask should be made of at least 2 layers of breathable fabric or hospital grade material, fully covers the nose, nostrils, mouth, and fits firmly under the chin, and fits snugly, but comfortably against the side of the face.
Do Not Attend if…
- Unvaccinated; all unvaccinated individuals will be denied entry.
- Exhibiting any symptoms or signs of sickness or have been in contact with known positive COVID-19 cases within 10 days of the 26th Winter Fluorine Conference.
- Testing positive for COVID-19 within the last 10 days from the start of the 26th Winter Fluorine Conference.
- Have had contact with a person that has or is suspected of having COVID-19 within fourteen (14) days from the start of the 26th Winter Fluorine Conference and have not completed a quarantine protocol.
Traveling to Attend
- Fully vaccinated against COVID-19 should still follow CDC’s recommendations for traveling safely including wearing a mask, staying 6 feet from others, and washing your hands or using hand sanitizer.
- If fully vaccinated against COVID-19 with an FDA-authorized vaccine or a vaccine authorized for emergency used by the World Health Organization one can travel safely within the United States.
- Fully vaccinated domestic travelers against COVID-19 do not need to get tested before or after travel unless their destination requires it. U.S. bound international travelers will need to be tested no more than 3 days before arrival in the U.S. and show their negative test results to the airline before you board the flight. Check with the CDC for guidelines on using some self-COVID-19 tests to meet entry.
On-Site Health & Safety Measures
- Anyone who has not uploaded their vaccination card or provided proof of a negative COVID-19 PCR test that has been taken within 48 hours of arriving at the conference will not be able to pick up a badge until proof of vaccination or negative COVID-19 PCR test has been verified.
- Signage will appear at any entrance alerting attendees that entry will be denied if they:
- Have not provided proof of being fully vaccinated or proof of a negative COVID-19 PCR test that has been taken within 48 hours of arriving at the conference
- Have been diagnosed with COVID-19,
- Are exhibited symptoms of COVID-19, or
- Have had contact with a person that has or is suspected of having COVID-19 within fourteen (14) days of the start of the 26th Winter Fluorine Conference and have not completed a quarantine protocol.
- Attendees must adhere to the requirements of any such signage while attending the 26th Winter Fluorine Conference. Failure to do so could result in the denial of entry or removal from the venue altogether.
- Plexiglass barriers may be used between registration staff and attendees as part of entry screening and registration.
Additional Safety Measures:
- Physical distancing in meeting rooms whenever space allows.
- Hand sanitizer stations will be located throughout the meeting space. It is the responsibility of each person to maintain personal hygiene, including washing your hands frequently for at 20 seconds with soap and warm water.
- Disinfectant wipes will also be available in every breakout room for disinfecting high-touch items used by presenters.
- Please observe physical distancing guidelines when greeting others. ACS Division of Fluorine Chemistry discourages handshaking, hugging, or any other unnecessary person-to-person contact.
- COVID-safe catering.
Contact Tracing & Privacy
- All attendees will be required to provide a working phone number to ACS Division of Fluorine Chemistry at the time of registration in case ACS Division of Fluorine Chemistry is notified by any government or local health department that contact tracing is required.
- The privacy of all attendees relative COVID-19 related situations will be respected at all times, including the secure and limited access to their data and the proper and timely disposal post-meeting.
COVID-19 TESTING STATION
(Closest PCR COVID-19 Testing Station Near Hotel)
Walgreens 703 Court St.
Clearwater, FL 33756
(Closet Hospital Near Hotel)
Morton Plant Hospital
300 Pinellas Street Clearwater, FL 33756
H. S. Bunn Distinguished Professor
Department of Chemistry, Lehigh University
6 E. Packer Ave.
Bethlehem, PA 18015
Loker Hydrocarbon Research Institute
University of Southern California
Los Angeles, CA 90089-1661
Housing and Registration Questions?